Biological activity of dihydroartemisinin in canine osteosarcoma cell lines
Kenji Hosoya(The Ohio State University), William C. Kisseberth(The Ohio State University)
Cited by 27
Related Papers
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma
|PLoS ONE|2016|58
Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis
|BMC Cancer|2017|46
Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines
|American Journal of Veterinary Research|2008|30